Clinical Trials Directory

Trials / Completed

CompletedNCT06121037

Greater Occipital Nerve Pulsed Radiofrequency for the Treatment of Combined Migraine and Cervicogenic Headache (New Approach)

Greater Occipital Nerve Pulsed Radiofrequency for the Treatment of Combined Migraine and Cervicogenic Headache (New Approach): Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Combined migraine and cervicogenic headache present significant challenges in clinical management due to their complex and overlapping pathophysiologies. Both conditions involve the trigeminocervical complex, suggesting a potential shared anatomical and neurobiological basis

Detailed description

Traditional treatment approaches for these headaches often include pharmacological interventions, but in cases of refractory or inadequate response, interventional techniques targeting the greater occipital nerve (GON) have gained attention. Radiofrequency ablation (RFA) has gained recognition as a potential therapeutic option for patients with refractory combined migraine and cervicogenic headaches. The proximal and distal ultrasound-guided approaches are widely utilized for GON RFA. These approaches aim to disrupt pain signals transmitted by the GON and provide relief of pain for these headache disorders

Conditions

Interventions

TypeNameDescription
PROCEDUREproximal ultrasound-guided GON radiofrequency ablationproximal GON radiofrequency
PROCEDUREdistal ultrasound-guided GON radiofrequency ablationdistal GON radiofrequency

Timeline

Start date
2022-01-01
Primary completion
2023-08-01
Completion
2023-09-01
First posted
2023-11-07
Last updated
2023-11-08

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06121037. Inclusion in this directory is not an endorsement.

Greater Occipital Nerve Pulsed Radiofrequency for the Treatment of Combined Migraine and Cervicogenic Headache (New Appr (NCT06121037) · Clinical Trials Directory